Description
Next-Generation Amylin Analogue & Metabolic Regulator
Ignite Cagrilitide (5mg) is a long-acting synthetic analogue of the hormone amylin. In the landscape of metabolic research, Cagrilitide is a highly sought-after compound for its role in regulating energy balance and glucose homeostasis. Unlike GLP-1 agonists, Cagrilitide operates via the amylin receptors to signal early satiety, making it a critical focus for studies involving multi-pathway weight management and metabolic synergy.
Primary Research Applications
-
Appetite & Satiety Signaling: Investigating the activation of amylin receptors in the hindbrain to reduce food intake and promote a feeling of fullness.
-
Gastric Emptying Regulation: Studying the peptide’s ability to slow the rate at which food leaves the stomach, leading to more stable post-meal glucose levels.
-
Synergistic Metabolic Research: Examining the effects of Cagrilitide when studied alongside GLP-1 receptor agonists (such as Semaglutide) for enhanced metabolic outcomes.
-
Glucagon Suppression: Analyzing the peptide’s role in inhibiting inappropriate glucagon secretion, a key factor in maintaining healthy blood sugar levels.
-
Energy Expenditure: Exploring how amylin analogues influence resting energy expenditure and lipid metabolism in metabolic models.
Product Specifications
-
Concentration: 5mg Lyophilized Powder
-
Purity Grade: 99%
-
Molecular Profile: Acylated peptide optimized for extended half-life and stability.
-
Quality Guarantee: Manufactured to the highest standards to ensure experimental reproducibility and precise data.
Disclaimer: This product is intended for laboratory research use only. It is not approved for human consumption, medical, or diagnostic use.
